KPMG
Description
As we edge toward the third decade of the century, business-as-usual methodologies no longer keep pace with the tides of innovation and unprecedented change.
Only logged in customers who have purchased this product may leave a review.
You may also like
-
PwcThis paper complements PwC’s Project Blue1 and the PwC Megatrends framework2, which examines the forces that are disrupting the role, structure, and competitive environment for financial institutions and the markets and societies in which they operate.
Financial Services Technology 2020 and Beyond
$0.00 Pwc
-
LEK
Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.
Artificial Intelligence in Life Sciences
$0.00 LEK
-
McKinsey
In 2007, medical leaders from across the pharmaceutical industry assembled to develop a common understanding of a ten-year vision for Medical Affairs. With five years now past, it is hardly surprising that significant change has occurred in the world in which the pharmaceutical industry operates, especially given the remarkable economic environment and the continued acceleration of technological change.
Pharma Medical Affairs 2020 and beyond
$0.00 McKinsey
Trouble with Conavigo
Trouble with Conavigo?
Contact our support team if you have trouble with the search results, your account, or your message box. We are here to help.
Ads Customers
Ads Consultants
Ads Students
Reviews
There are no reviews yet.